[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371773-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371773-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","real-world-safety-of-irreversible-electroporation-therapy-for-tumors-with-nanoknife-maude-database-analysis","Real-world safety of irreversible electroporation therapy for tumors with nanoknife - MAUDE database analysis","","Irreversible electroporation (IRE) is a non-thermal ablation technique that uses high-voltage, low-energy pulses to induce cell membrane perforation and cell death. Using the MAUDE database, the study evaluates real-world adverse event reports related to IRE with the Nanoknife device. Analyses characterize adverse event types, Clavien-Dindo grades, and temporal patterns across cancers. Results identify device malfunctions as a major but declining issue, with cancer-specific injury profiles.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/real-world-safety-of-irreversible-electroporation-therapy-for-tumors-with-nanoknife-maude-database-analysis/371773/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/real-world-safety-of-irreversible-electroporation-therapy-for-tumors-with-nanoknife-maude-database-analysis/371773.png","ImageObject",300,407,{"name":42,"@type":43},"McGucket","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is irreversible electroporation (IRE) and how does it work with Nanoknife?","Question",{"text":63,"@type":64},"IRE is a non-thermal ablation method using high-voltage, low-energy pulses to perforate cell membranes and cause cell death. Nanoknife is the most widely used device for this therapy, aiming to spare surrounding functional structures like blood vessels and nerves.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was safety evaluated in the study?",{"text":68,"@type":64},"The study analyzed all IRE-related adverse event reports in the MAUDE database. It focused on event types, Clavien-Dindo grades, the timing of adverse events, and temporal trends across different cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"What key adverse events were reported for different cancer types?",{"text":72,"@type":64},"Device malfunctions with Nanoknife were a significant issue but declined in recent years. Pancreatic cancer reports most commonly included gastrointestinal injuries, mainly hemorrhagic lesions; liver cancer reports highlighted arrhythmias; prostate cancer most often reported rectal fistula, with an increasing number of cases over time.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371773,1790274258,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Xiang et al. BMC Surgery (2025) 25:390 [https://doi.org/10.1186/s12893-025-03136-9](https://doi.org/10.1186/s12893-025-03136-9)  \nBMC Surgery  \nRESEARCH Open Access  \nReal-world safety of irreversible electroporation therapy for tumors with nanoknife: MAUDE database analysis  \nJia-Cheng Xiang 1†, Zhi-Yu Xia 1†, Jian-Xuan Sun 1, Shao-Gang Wang 1* and Qi-Dong Xia 1*  \nAbstract  \nBackground Irreversible electroporation (IRE) is a non-thermal ablation technique using high-voltage, low-energy pulses to induce cell membrane perforation and cell death. As an emerging therapy, IRE has gained increasing application in local tumor treatment, with Nanoknife being the most widely used device. Despite its relative safety compared to traditional therapies, potential adverse reactions still merit the attention of clinicians.  \nMethods We analyzed all IRE-related adverse event reports in the Manufacturer and User Facility Device Experience (MAUDE) database, focusing on event types, Clavien-Dindo Grades, the timing of adverse events and temporal trends across cancers.  \nResults Device malfunctions with Nanoknife were a significant issue but have declined recently. In pancreatic cancer, gastrointestinal injuries (mainly hemorrhagic lesions) were most commonly reported. In liver cancer, arrhythmias were frequent, with no new cases in recent years. In prostate cancer, rectal fistula was the most common adverse event, with an increasing number of cases being reported.  \nConclusions Theoretically, the Nanoknife is expected to exhibit favorable safety profiles. However, ongoing attention to device maintenance, treatment standardization, and postoperative management is needed to further enhance its safety.  \nKeywords Cancer, Irreversible electroporation, Nanoknife, IRE, Adverse events, Safety  \n†Jia-Cheng Xiang and Zhi-Yu Xia contributed equally to this work.  \n*Correspondence:  \nShao-Gang Wang [sgwangtjm@163.com](sgwangtjm@163.com)[ ](sgwangtjm@163.com)Qi-Dong Xia [qidongxia_md@163.com](qidongxia_md@163.com)  \n1Department and Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Wuhan, Wuhan 430030, P. R. China  \nIntroduction  \nThe high incidence and complex treatment of malignant tumors remain a significant challenge in the medical field. Traditional therapeutic modalities such as surgical resection, radiotherapy, and chemotherapy, despite their widespread application, are often associated with limitations including tissue damage, drug resistance, and systemic toxic side effects. While for tumors located adjacent to blood vessels and nerves, thermal ablation techniques may cause irreversible damage to surrounding tissues due to heat diffusion and can even lead to severe complications [1–3]. With the development of advanced medical technologies has revolutionized cancer treatment,  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nXiang et al. BMC Surgery (","cbCaiuIToHArnQ0Q","https://ap.wps.com/l/cbCaiuIToHArnQ0Q","pdf",1812083,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Rationale for IRE versus thermal ablation\n## Reported adverse risks and rationale for analysis\n# Table 1: Clavien-Dindo grade overview","[{\"question\":\"What is irreversible electroporation (IRE) and how does it work with Nanoknife?\",\"answer\":\"IRE is a non-thermal ablation method using high-voltage, low-energy pulses to perforate cell membranes and cause cell death. Nanoknife is the most widely used device for this therapy, aiming to spare surrounding functional structures like blood vessels and nerves.\"},{\"question\":\"How was safety evaluated in the study?\",\"answer\":\"The study analyzed all IRE-related adverse event reports in the MAUDE database. It focused on event types, Clavien-Dindo grades, the timing of adverse events, and temporal trends across different cancers.\"},{\"question\":\"What key adverse events were reported for different cancer types?\",\"answer\":\"Device malfunctions with Nanoknife were a significant issue but declined in recent years. Pancreatic cancer reports most commonly included gastrointestinal injuries, mainly hemorrhagic lesions; liver cancer reports highlighted arrhythmias; prostate cancer most often reported rectal fistula, with an increasing number of cases over time.\"}]","Real-world safety of irreversible electroporation therapy for tumors with nanoknife - MAUDE database analysis | PDF",1790192833,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef0f1b2df66938dc4e75a41dd13ee62c.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3de565f7c3f12dfe995ab3d0c5cd114.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93c56dbf2d826ad9520b70cc83b9a905.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0320e74ffc845790696295a3569b9577.webp",980,1306]